Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Mesa Labs Inc (MLAB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 762,262
  • Shares Outstanding, K 3,850
  • Annual Sales, $ 96,180 K
  • Annual Income, $ -2,960 K
  • 36-Month Beta 0.27
  • Price/Sales 7.92
  • Price/Cash Flow 22.75
  • Price/Book 7.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.40
  • Number of Estimates 1
  • High Estimate 1.40
  • Low Estimate 1.40
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +683.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
169.80 +17.44%
on 10/23/18
201.79 -1.17%
on 11/13/18
+21.32 (+11.97%)
since 10/16/18
3-Month
167.34 +19.17%
on 10/15/18
212.58 -6.19%
on 08/22/18
-3.57 (-1.76%)
since 08/16/18
52-Week
122.35 +63.00%
on 01/02/18
224.95 -11.35%
on 07/13/18
+67.03 (+50.63%)
since 11/16/17

Most Recent Stories

More News
Mesa Labs: Fiscal 2Q Earnings Snapshot

LAKEWOOD, Colo. (AP) _ Mesa Laboratories Inc. (MLAB) on Wednesday reported fiscal second-quarter earnings of $994,000.

MLAB : 199.42 (+0.72%)
Mesa Labs Reports Record Second Quarter Revenues

Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today reported record revenues for the second quarter ended September 30, 2018.

MLAB : 199.42 (+0.72%)
Mesa Labs Declares Quarterly Dividend

Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The...

MLAB : 199.42 (+0.72%)
Neovasc (NVCN) Looks Good: Stock Adds 7.4% in Session

Neovasc (NVCN) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

MLAB : 199.42 (+0.72%)
NVCN : 1.41 (-3.42%)
Guest Host Tonight

Guest Host Tonight

CDXS : 16.90 (+4.32%)
WK : 36.20 (-1.98%)
MLAB : 199.42 (+0.72%)
Edwards Lifesciences (EW) in Focus: Stock Moves 7.7% Higher

Edwards Lifesciences (EW) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

EW : 155.71 (+1.69%)
MLAB : 199.42 (+0.72%)
Mesa Laboratories (MLAB) Enters Oversold Territory

Mesa Laboratories, Inc. (MLAB) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

MLAB : 199.42 (+0.72%)
Mesa Labs Reports Transition of its Chief Sales and Marketing Officer

Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today reported that Greg DiNoia has been appointed to lead Commercial Operations as Senior Vice President, succeeding Glenn...

MLAB : 199.42 (+0.72%)
Mesa Labs Declares Quarterly Dividend

- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, "Mesa" or the "Company") today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock....

MLAB : 199.42 (+0.72%)
MedTech's Long-Term Prospects Outweigh Near-Term Risks

MedTech's Long-Term Prospects Outweigh Near-Term Risks

ENTL : 24.00 (-0.04%)
TNDM : 33.49 (+1.12%)
SYK : 172.16 (+2.04%)
MLAB : 199.42 (+0.72%)
VAR : 118.76 (+1.57%)
BSX : 37.21 (+2.03%)
JNJ : 145.99 (+1.03%)
RMD : 104.18 (-0.05%)
BABY : 33.93 (+8.06%)
ICUI : 242.49 (-0.60%)
HAE : 110.80 (+2.34%)
WMGI : 29.54 (+3.14%)
ABT : 72.04 (+1.85%)
SRDX : 59.49 (+0.66%)
LIVN : 125.42 (+2.04%)
BDX : 246.07 (+2.51%)
HRC : 94.42 (+1.80%)
MDT : 93.70 (+1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade MLAB with:

Business Summary

MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.

See More

Key Turning Points

2nd Resistance Point 202.47
1st Resistance Point 200.95
Last Price 199.42
1st Support Level 196.95
2nd Support Level 194.47

See More

52-Week High 224.95
Last Price 199.42
Fibonacci 61.8% 185.75
Fibonacci 50% 173.65
Fibonacci 38.2% 161.54
52-Week Low 122.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar